Feds Take Action Against Cannabis Chemical CBD Despite Benefit To Patients With Seizures, Coors Sees Marijuana as a 'Risk Factor'
Feds Take Action Against Cannabis Chemical CBD Despite Benefit To Patients With Seizures
Imagine this: Your first-born child all of a sudden has hundreds of seizures a day, and not a single drug prescribed by your doctor works. What would you do?
A South Bay couple took a giant leap of faith, but as Kiet Do reports the treatment they’re using is at the center of an important court case. Read more.
Molson Coors Calls Legal Marijuana a “Risk Factor” for its Beer Business
Molson Coors Brewing Co. now considers legal cannabis a potential “risk factor” to its business. Molson Coors, which maintains headquarters in Denver and Montreal, on Wednesday joined the growing ranks of established, traditional publicly traded companies to address the burgeoning marijuana industry in annual financial reports filed with the U.S. Securities and Exchange Commission. Read more.
Federal Appeals Court Hears Hemp Industry Lawsuit Challenging DEA’s Position on CBD
The fate of a federal rule viewed by hemp advocates as an existential threat to their emerging industry is now in the hands of a three-judge panel.
The DEA’s rule epitomizes “government overreach” and stands in opposition to intervening legislation, Robert Hoban, a Denver-based attorney representing the hemp industry, told the 9th Circuit Court judges. Read more.
Bill to Resolve Marijuana Tax Error Heads to Hickenlooper's Desk
A bill designed to address a 2017 lawmaking error that inadvertently withheld marijuana tax revenue from special districts across the state has sped through the Colorado Legislature in less than a month, and is now headed to Governor John Hickenlooper's desk. Read more.